Intimation about the appointment of Cost Auditor of the company for the financial year 2025-2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences has informed the stock exchanges about the appointment of a Cost Auditor for the financial year 2025-2026. This is a routine regulatory requirement under the Companies Act, under which certain companies must get their cost records audited by a qualified cost accountant. The appointment is for one financial year and is typically approved by the Board of Directors. No financial details or the name of the auditor were highlighted in the intimation. This is a standard compliance filing and does not indicate any operational or governance changes.
This is a routine compliance announcement with no material impact on shareholders or the stock price. It simply fulfils a regulatory requirement to have cost records audited for the upcoming financial year.